CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells - ScienceDirect
Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities: Trends in Cancer
IJMS | Free Full-Text | Extracellular Vesicles as Biomarkers Carriers in Bladder Cancer: Diagnosis, Surveillance, and Treatment
Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39 | Journal of Medicinal Chemistry
The distinct role of CD73 in the progression of pancreatic cancer | SpringerLink
Cancers | Free Full-Text | CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors | PNAS
CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis | Journal of Hematology & Oncology | Full Text
Cancers | Free Full-Text | Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles
CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model | BMC Cancer | Full Text
CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint | Nature Communications
Cancers | Free Full-Text | Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various Cancers
CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model | BMC Cancer | Full Text
CD73 expression in different cancer cell lines. | Download Table
CD73 is a hypoxia-responsive gene and promotes the Warburg effect of human gastric cancer cells dependent on its enzyme activity
Ecto‐5′‐nucleotidase (CD73) is a potential target of hepatocellular carcinoma - Shali - 2019 - Journal of Cellular Physiology - Wiley Online Library
Targeting CD73 to augment cancer immunotherapy - ScienceDirect
CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth
Frontiers | Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
Cancers | Free Full-Text | Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-β-Catenin Signaling
Molecular principles of metastasis: a hallmark of cancer revisited | Signal Transduction and Targeted Therapy
CD73 as a novel marker for poor prognosis of oral squamous cell carcinoma
Targeting CD73 to augment cancer immunotherapy - ScienceDirect
Frontiers | CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
